6:30 AM SIGN-IN & BREAKFAST • 7:00 AM - 8:30 AM
BANDOL 2 (NEW WYNN SPACE)
CE: Hereditary Angioedema: Outlining the Differences Between Current and Emerging Therapies
Hereditary angioedema (HAE) is a rare disease characterized by recurring episodes of subcutaneous or submucosal edema, most commonly in the face, gastrointestinal tract, and upper airway. Misdiagnosis of HAE and subsequent emergency department visits, hospital stays, and other indirect costs contribute to its substantial burden. If left untreated, patients with HAE may experience multiple and life-threatening attacks, require more frequent medical interventions, and incur considerable economic costs. Specialty pharmacists must be well informed of the nuances between current recommendations for acute attacks and prophylaxis including C1-INH therapies, kallikrein inhibitors, and bradykinin receptor antagonists to provide patients with individualized treatment plans and proper recommendations for self-administration. This activity will equip pharmacists with the knowledge necessary to educate and counsel patients on appropriate medication use for effective and safe management of HAE attacks.